Apolipoprotein E ε4 and the risk of dementia with stroke: A population- based investigation

JAMA

Volumn 277, Issue 10, 1997, Pages 818-821

  Slooter, Arjen J C ^a,c   Tang, Ming Xin ^a,b   Van Duijn, Cornelia M ^c   Stern, Yaakov ^a,b   Ott, Alewijn ^c   Bell, Karen ^b   Breteler, Monique M B ^c   Van Broeckhoven, Christine ^d,e   Tatemichi, Thomas K ^a,b   Tycko, Benjamin ^b   Hofman, Albert ^c   Mayeux, Richard ^a,b  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b Erasmus University Medical School ^*  (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NETHERLANDS; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; STROKE; UNITED STATES; ALLELE; ANALYSIS OF VARIANCE; CEREBROVASCULAR DISEASE; DEMENTIA; ETHNOLOGY; GENE FREQUENCY; GENETICS; NEUROPSYCHOLOGICAL TEST; RISK FACTOR; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; ALLELES; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; DEMENTIA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS;

EID: 0030614814     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.10.818     Document Type: Article

References (32)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high affinity binding to beta-amyloid and increased frequency of type 4 allele in late-onset Alzheimer's disease. Proc Natl Acad Sci USA. 1993;90:1977-1981.
2. Corder EH, Saunders AM, Risen NJ, et al. Protective effect of apolipoprotein E type 2 allele for late-onset Alzheimer disease. Nat Genet. 1994;7: 180-184.
3. van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet. 1994; 1:74-78.
4. Henderson AS, Easteal S, Jorm AF, et al. Apolipoprotein E allele ∈4, dementia, and cognitive decline in a population sample. Lancet. 1995;346:1387-1390.
5. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol. 1995;37:254-259.
6. Frisoni GB, Calabresi L, Geroldi C, et al. Apolipoprotein E ∈4 allele in Alzheimer's disease and vascular dementia. Dementia. 1994;5:240-242.
7. Pirttilä T, Lehtimäki T, Rinne J, Mattila K, Frey H, Nikkari T. The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia. Acta Neurol Scand. 1996;93:352-354.
8. Noguchi S, Murakami K, Yamada N. Apolipoprotein E genotype and Alzheimer's disease. Lancet. 1993;342:737.
9. Sakoda S, Kuriyama M, Osame M, et al. Apolipoprotein E ∈4. Neurology. 1994;44:2420.
10. Bétard C, Robitaille Y, Gee M, et al. Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. Neuroreport. 1994;5:1893-1896.
11. Mahieux F, Coudera R, Moulignier A, Bailleul S, Podrabinek N, Laudet J. Isoforme 4 de l'apolipoprotéine E et maladie d'Alzheimer: spécificité et étude clinique [isoform 4 of apolipoprotein E and Alzheimer's disease: specificity and clinical study]. Rev Neurol (Paris). 1995;151:231-239.
12. Stengård JH, Pekkanen J, Sulkava R, et al. Apolipoprotein E polymorphism, Alzheimer's disease and vascular dementia among elderly Finnish men. Acta Neurol Scand. 1995;92:297-298.
13. Hofman A, Grobbee DE, De Jong PTVM, et al. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991;7:403-422.
14. Ott A, Breteler MMB, Van Harskamp F, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education: the Rotterdam study. BMJ. 1995;310:970-973.
15. Pittman J, Andrews H, Tatemichi T, et al. Diagnosis of dementia in a heterogenous population: a comparison of paradigm-based diagnosis and physician's diagnosis. Arch Neurol. 1992;49:461-467.
16. Stern Y, Andrews H, Pittman J, et al. Diagnosis of dementia in a heterogenous population: development of a neuropsychological paradigm and quantified correction for education. Arch Neurol. 1992;49:453-460.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987.
18. World Health Organization. International Statistical Classification of Diseases and Related Health, Problems: 10th Revision. Geneva, Switzerland: World Health Organization; 1992.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Workgroup under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
20. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-260.
21. Census of Population and Housing, 1990: Summary Tape File 1. Washington, DC: US Bureau of the Census; 1991.
22. Hixson J, Vernier D. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhAI. J Lipid Res. 1991;31:545-548.
23. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991;337:1158-1159.
24. Couderc R, Mahieux F, Bailleul S, Fenelon G, Mary R, Fermanian J. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: a case-control study. Stroke. 1993;4:661-664.
25. Pedro-Botet J, Sentí M, Nogués X, et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke: role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke. 1992;23:1556-1562.
26. Kuusisto J, Mykkanen L, Kervinen K, Kesaniemi YA, Laakso M. Apolipoprotein E4 phenotype is not an important factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol. 1995;15:1280-1286.
27. Alberts MJ, Graffagnino C, McClenny C, et al. ApoE genotype and survival from intracerebral haemorrhage. Lancet. 1995;346:575.
28. Kida E, Pluta R, Lossinsky AS, et al. Complete cerebral ischemia with short-term survival in rat induced by cardiac arrest, II: extracellular and intracellular accumulation of apolipoproteins E and J in the brain. Brain Res. 1995;674:341-346.
29. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 1994;17:525-530.
30. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8:1-21.
31. Marder K, Richards M, Bello J, et al. Clinical correlates of Alzheimer's disease with and without silent radiographic abnormalities. Arch Neurol. 1995; 52:146-151.
32. Mirra SS, Markesbery WR. The neuropathology of Alzheimer's disese: diagnostic features and standardization. In: Khaehaturian ZS, Radebaugh TS, eds. Alzheimer's Disease: Causes, Diagnosis, Treatment and Care. Boca Raton, Fla: CRC Press; 1996:111-123.